Adiponectin: From obesity to cardiovascular disease: Etiology and Pathophysiology
Adiponectin is an adipokine whose biosynthesis is deranged in obesity and diabetes mellitus, predisposing to atherosclerosis. Evidence suggests that adiponectin has anti-atherogenic properties by improving endothelial function and having anti-inflammatory effects in the vascular wall. In addition, a...
Main Authors: | Antoniades, C, Antonopoulos, A, Tousoulis, D, Stefanadis, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Adiponectin: from obesity to cardiovascular disease.
by: Antoniades, C, et al.
Published: (2009) -
Adiponectin as a Biomarker at Different Stages of Ischaemic Heart Disease: From Obesity to Ischaemic Heart Failure
by: Antonopoulos, A, et al.
Published: (2009) -
Is vascular superoxide triggering adiponectin biosynthesis in perivascular adipose tissue in patients with atherosclerosis?
by: Bakogiannis, C, et al.
Published: (2010) -
Genetic Variability of Adiponectin Gene Defines the Biosynthesis Rate of Adiponectin in Adipose Tissue and Regulates Superoxide Generation in Human Arteries in vivo
by: Antoniades, C, et al.
Published: (2010) -
Assessing inflammatory status in cardiovascular disease.
by: Tousoulis, D, et al.
Published: (2007)